论文部分内容阅读
Parkinson’sdisease-mildcognitiveimpairment(PD-MCI)currently represents a valid diagnostic clinical entity with potential interest for therapeutic purpose.MCI is present in approximately 25–30%of non-demented patients with PD(Weintraub et al.,2018).Several